Euromedic International Overview July 2013

1. Euromedic International
Company Overview

2. Euromedic Overview
 Euromedic International a Dutch Holding Company, is the largest Pan - European
investor and operator of Public Private Partnership (PPP) related healthcare services.
 Euromedic’s shareholders are Ares Life Sciences, the leading Swiss Healthcare
investor and Montagu Private Equity a London based leading Private Equity Fund.
 The company operates high quality medical centres in the fields of Radiology, Clinical
Laboratories and Cancer Treatment Centres in 15 countries around Europe.
 Euromedic medical equipment installed base and the replacement capital
expenditure is same size as the Netherlands.
 The company is the leading private provider in related healthcare services in most of
the markets in which it operates.
 Euromedic employs over 3,000 people, of which more than 790 are Medical Doctors.
 The company Executive HQ is located in Budapest, Hungary.

3. Euromedic Pan-European Platform
Diagnostic Centres 2
Laboratories 4
Diagnostic Centres 35
Cancer Treatment 4
Diagnostic Centres 9
Diagnostic Centres 6
Diagnostic Centres 10
Laboratories 4
Diagnostic Centres 8
Diagnostic Centres 1
Diagnostic Centres 11
Diagnostic Centres 9
Laboratories 1
Diagnostic Centres 7
Diagnostic Centres 5
Diagnostic Centres 10
Diagnostic Centres 2
Cancer Treatment 1
Diagnostic Centres 12
Cancer Treatment 2
 Active in 15 countries in Europe.
 Operates over 693 diagnostic modalities and 13 Linacs
in 143 Medical Centres across Europe.
 Employs 793 Doctors
 Serve 4 Million Patients annually.
 Annually performs more than
3 Million Examinations,
93 thousand radiotherapy fractions
and 13 Million Lab tests.

4. Euromedic Mission
 Provide Diagnostic Investigations and Cancer Treatments with Medical Excellence
for the benefit of our Patients and the Medical Community,
 Perform our services Efficiently for the benefit of the state authorities and national
healthcare structures,
 Act with Integrity in every aspect of our business operations.”

5. • Equipment Mngt
• Asset Utilization
• Maintenance Mngt
• Digital Environment
• Filmless, VR, TeleRad
• Medical Advisory Board
• ESR / ESOR / Webinars
• Structured Reporting
• Advanced Examinations
• Imaging Protocols
• Operational KPIs
• Facilities’ Constructions
• Efficient Procurement
• Lean Management
• Patient Flows
• Care Standardization
• EHS, Patient Safety
• Patient Surveys
• Clinical Audit
• Care Accreditation
Medical Knowledge Medical Outcome
Technology
Care Processes
Organisation
55

6. Radiological Diagnostic Imaging Centres
 Euromedic currently operates its Radiological
Diagnostic Imaging Division via a network of 127
centres spread across 14 countries
 The Company has a broad pipeline of business
development opportunities in several European
countries.
 Euromedic performs over 3 Million diagnostic
investigations annually.
 Euromedic owns and operates close to 700 modern
radiological modalities that includes 109 MRI’s, 84
CT’s and 15 PET-CT’s as part of the installed base.

7. Cancer Treatment Centres
 Euromedic provides life saving radiotherapy services
through a network of 7 centers located in Poland,
Turkey and Bosnia.
 Centers are equipped with state-of-the-art
therapeutic devices that enable our doctors to
deliver the most accurate treatment of cancer.
 More than 12,000 patients are treated annually in
Euromedic Cancer Treatment Centres.
 Affiliation agreement with Methodist International,
(a global subsidiary of The Methodist Hospital in
Houston, Texas) which defines intensive cooperation
directed towards the exchange of best medical
practices, education of Euromedic doctors and
quality management.

8. Clinical Laboratory Centres
 Euromedic entered the Laboratory Business in late
2006 and subsequently has established a foothold
in the market. The company now owns and
operates laboratories in Greece, Czech Republic,
Romania, Turkey and Portugal. Euromedic
performs over 13 Million clinical laboratory
investigations annually.
 A typical laboratory is equipped to investigate
Haematology, Biochemistry, Immunology,
Microbiology and Molecular Biology examinations.
 The company is in process of certifying all of its labs
with ISO 15189 International Standards.

9. Highly Supportive Shareholders Base
Leading private equity investor in the European
mid-market, currently has c.€3bn of funds and
assets under management.
Focused on investing in management buyouts
in partnership with the incumbent
management team
Investment venture backed by Ernesto
Bertarelli. Ares actively seeks and invests in
EU based healthcare opportunities
The fund is focused on five specific sectors:
Pharmaceuticals, Biotechnology, Diagnostics,
Medical Technology and Healthcare services
Description
Selected
Portfolio